Literature DB >> 15614061

Hemivertebra excision in children via simultaneous anterior and posterior exposures.

Daniel J Hedequist1, John E Hall, John B Emans.   

Abstract

This study evaluates the effectiveness of hemivertebra excision in children via simultaneous anterior and posterior operative exposures. This study was a retrospective review of patients treated with this technique over a 5-year period with minimum 2-year follow-up. Eighteen patients were studied, all of whom had undergone hemivertebra excision and deformity correction using unilateral compression instrumentation. The average age of the patients at the time of operation was 3 years 2 months and the average preoperative coronal curve measured 40 degrees. There were no neurologic complications. At an average follow-up of 35 months all patients had obtained bony fusion; the average coronal curve measured 11 degrees for an average percentage correction of 71%. Hemivertebra excision by simultaneous exposure is an effective and safe way of managing congenital hemivertebra, and the correction is similar to staged anterior-posterior procedures or posterior-only procedures.

Entities:  

Mesh:

Year:  2005        PMID: 15614061     DOI: 10.1097/00004694-200501000-00014

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  11 in total

Review 1.  Surgical outcomes following hemivertebrectomy in congenital scoliosis: a systematic review and observational meta-analysis.

Authors:  Sitanshu Barik; Dipun Mishra; Tushar Gupta; Gagandeep Yadav; Pankaj Kandwal
Journal:  Eur Spine J       Date:  2021-03-19       Impact factor: 3.134

2.  Posterior hemivertebrectomy and short segment fixation-long term results.

Authors:  Saumyajit Basu; Agnivesh Tikoo
Journal:  Childs Nerv Syst       Date:  2016-12-17       Impact factor: 1.475

3.  The efficacy and complications of posterior hemivertebra resection.

Authors:  Jianguo Zhang; Wang Shengru; Guixing Qiu; Bin Yu; Wang Yipeng; Keith D K Luk
Journal:  Eur Spine J       Date:  2011-02-12       Impact factor: 3.134

4.  The Efficacy of Single-Stage Correction by Posterior Approach for Neglected Congenital Scoliosis: Comparative Analysis According to the Age of Surgical Intervention.

Authors:  Jae Hyuk Yang; Hong Jin Kim; Dong-Gune Chang; Seung Woo Suh; Yunjin Nam; Jae-Young Hong
Journal:  J Clin Med       Date:  2022-04-19       Impact factor: 4.964

5.  Congenital scoliosis - Quo vadis?

Authors:  Ujjwal K Debnath; Vivek Goel; Nanjanduppa Harshavardhana; John K Webb
Journal:  Indian J Orthop       Date:  2010-04       Impact factor: 1.251

6.  Hemivertebrae resection for unbalanced multiple hemivertebrae: is it worth it?

Authors:  Chunguang Zhou; Limin Liu; Yueming Song; Hao Liu; Tao Li; Quan Gong; Jiancheng Zeng; Qingquan Kong
Journal:  Eur Spine J       Date:  2013-10-27       Impact factor: 3.134

7.  Posterior hemivertebra resection with bisegmental fusion for congenital scoliosis: more than 3 year outcomes and analysis of unanticipated surgeries.

Authors:  Shengru Wang; Jianguo Zhang; Guixing Qiu; Shugang Li; Bin Yu; Xisheng Weng
Journal:  Eur Spine J       Date:  2012-11-21       Impact factor: 3.134

8.  Comparison of one-stage anteroposterior and posterior-alone hemivertebrae resection combined with posterior correction for hemivertebrae deformity.

Authors:  Lei Wang; Yuemin Song; Fuxing Pei; Limin Liu; Hao Liu; Qingquan Kong; Tao Li; Jiancheng Zeng
Journal:  Indian J Orthop       Date:  2011-11       Impact factor: 1.251

9.  Posterior hemivertebra resection and monosegmental fusion in the treatment of congenital scoliosis.

Authors:  X Zhu; X Wei; J Chen; C Li; M Li; Y Qiao; B Ran
Journal:  Ann R Coll Surg Engl       Date:  2014-01       Impact factor: 1.891

10.  The radiological outcomes of one-stage posterior-only hemivertebra resection and short segmental fusion for lumbosacral hemivertebra: a minimum of 5 years of follow-up.

Authors:  Yu Wang; Zhen Liu; Changzhi Du; Benlong Shi; Xu Sun; Bin Wang; Zezhang Zhu; Yong Qiu
Journal:  J Orthop Surg Res       Date:  2019-12-11       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.